Episode breakdown:
00:00 – Intro: Why April Was a Pivotal Month for Medtech
01:52 – Supira Medical Raises $120M for pVAD Innovation
05:34 – CMR Surgical’s $200M Robotics Bet
09:12 – Edwards Lifesciences Gets CE Mark for Sapien M3
13:01 – Biolinq’s $100M Needle-Free Glucose Monitor
15:27 – AI + Imaging: Anumana and Conavi Raise Big
18:40 – The Numbers: 3 Fastest-Growing Procedure Segments
21:45 – The APAC Expansion Opportunity for Medtech
24:15 – NAMSA, FDA, and the New Clinical-First Strategy
27:00 – Closing Thoughts: What to Watch Going into May
Meet me in NYC this May at MD&M East May 20-22! Get a free expo pass and see my keynote on Wednesday May 21st! Click here and use code OMAR25 https://utm.io/uidBR
Don’t Let Cybersecurity Risks Delay Your Medical Device Premarket Approval. Check out BlueGoatCyber.com
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
